What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Colorectal cancer, Internal medicine, Cancer research, Oncology and Cancer.
The Colorectal cancer study combines topics in areas such as Chemotherapy, Survival rate, Pathology, Immunology and Microsatellite instability.
He combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
His Cancer research research incorporates elements of Cancer cell, Carcinogenesis, Tumor suppressor gene, Immune system and Loss of heterozygosity.
His Oncology study combines topics in areas such as Bioinformatics, Multivariate analysis, Irinotecan, KRAS Mutation Analysis and Bevacizumab.
His studies deal with areas such as Mutation and PTEN as well as Cancer.
His most cited work include:
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease (4710 citations)
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer (1905 citations)
- The consensus molecular subtypes of colorectal cancer (1870 citations)
What are the main themes of his work throughout his whole career to date?
Pierre Laurent-Puig mainly investigates Internal medicine, Oncology, Colorectal cancer, Cancer research and Cancer.
His research on Internal medicine often connects related topics like Gastroenterology.
His study in Oncology is interdisciplinary in nature, drawing from both Stage, Biomarker, FOLFOX and Bioinformatics.
His research integrates issues of Immunology, Microsatellite instability, Genotype and Pathology in his study of Colorectal cancer.
His Cancer research research is multidisciplinary, relying on both Mutation, Tumor suppressor gene, Gene, Carcinogenesis and Loss of heterozygosity.
His KRAS research focuses on Molecular biology and how it connects with Genetics.
He most often published in these fields:
- Internal medicine (50.72%)
- Oncology (38.28%)
- Colorectal cancer (38.28%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (50.72%)
- Oncology (38.28%)
- Colorectal cancer (38.28%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Colorectal cancer, Cancer research and Cancer.
Within one scientific family, Pierre Laurent-Puig focuses on topics pertaining to Proportional hazards model under Oncology, and may sometimes address concerns connected to Randomized controlled trial.
His studies in Colorectal cancer integrate themes in fields like Survival analysis, Prospective cohort study, Surgery, Microsatellite instability and Bevacizumab.
His Cancer research research focuses on Immune system and how it relates to Pathology.
The study incorporates disciplines such as Mutation, Digital polymerase chain reaction and Bioinformatics in addition to Cancer.
His KRAS research includes themes of Lung cancer and Adenocarcinoma.
Between 2015 and 2021, his most popular works were:
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer (1308 citations)
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability (520 citations)
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability (520 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Internal medicine, Oncology, Colorectal cancer, Cancer and KRAS.
His work in Internal medicine tackles topics such as Surgery which are related to areas like mir-31 and Post-hoc analysis.
His research in Oncology intersects with topics in Cetuximab, Clinical trial, FOLFOX and Prospective cohort study.
The various areas that Pierre Laurent-Puig examines in his Colorectal cancer study include Cancer research, Microsatellite instability, Pathology, Biomarker and Survival analysis.
His Cancer research is multidisciplinary, incorporating perspectives in Mutation, Digital polymerase chain reaction and Chemotherapy.
Pierre Laurent-Puig has included themes like DNA Mutational Analysis, Computational biology and Adenocarcinoma in his KRAS study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
